Back to the NewsWire

Biorxiv

Published September 7, 2026

Ketamine Modulates Endogenous Opioid Peptide Signaling and Reduces Heroin-Seeking ...

Ketamine , a non-competitive N-Methyl-D-Aspartate receptor (NMDAR) antagonist, has emerged as a promising therapeutic for numerous psychiatric.

Read the full story at Biorxiv

Surfaced by this Google Alert

  • Ketamine